Agenda

Return

C.112

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	May 22, 2018

Contra

Costa

County

Subject:

Software and Services Agreement #23-637 with CapsuleTech, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 05/22/2018

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Patrick Wilson, 925-335-8700
cc:	Tasha Scott Marcy Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: May 22, 2018
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County, Software and Services Agreement #23-637 with CapsuleTech, Inc., in an amount not to exceed $86,891 for the renewal of SmartLinx (formerly DataCaptor) License, Maintenance and Support for the period of March 6, 2018 through March 5, 2021.

FISCAL IMPACT:

100% funding is included in the Hospital Enterprise Fund I Budget.

BACKGROUND:

Health Services Department uses the SmartLinx (formerly known as DataCaptor) application for Medical Device Information Systems Support for clinical staff. The product facilitates interfacing between medical devices and medical software by collecting data, translating data into a common protocol, processes if necessary, merges data into a single flow, and distributes to medical software. SmartLinx delivers monitoring, management, and analysis of real-time patient data to the EPIC System.

BACKGROUND: (CONT'D)

Software and Services Agreement #23-637 contains a mutual indemnification provision regarding third party claims, which requires the County to indemnify and defend CapsuleTech, Inc. for claims arising out of the unauthorized use of the products.

CONSEQUENCE OF NEGATIVE ACTION:

Failure to renew this application would not enable clinicians to recognize the signs of a patient’s physiological deterioration and take prompt action before the onset of adverse events; as well as providing interface of medical devices and information flow to distribute patient data between EPIC.